In the largest penalty of its kind involving a drug maker, Teva Pharmaceutical agreed to pay more than $519 million to settle civil and criminal charges of violating the Foreign Corrupt Practices Act for bribing foreign government officials in Russia, Ukraine, and Mexico.

Federal authorities alleged that Teva made more than $214 million in illicit profits by making “influential payments” to increase its market share and win regulatory and formulary approvals, as well as favorable drug purchases and prescriptions written by health care providers.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy